Welcome to our dedicated page for Silicon Labs SEC filings (Ticker: SLAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Silicon Laboratories Inc. (Silicon Labs, NASDAQ: SLAB) SEC filings, offering investors and analysts a primary view into the company’s regulatory disclosures. As a public semiconductor company focused on low-power wireless connectivity and embedded technology, Silicon Labs uses filings such as Forms 10-K, 10-Q, and 8-K to report its financial condition, risk factors, and material events.
In recent Form 8-K filings, Silicon Labs has reported quarterly results and explained its use of non-GAAP financial measures alongside GAAP metrics. These disclosures describe how the company adjusts for items like stock compensation expense, intangible asset amortization, acquisition- and disposition-related items, termination costs and impairments, equity-method investment adjustments, certain interest expense items, and income tax adjustments based on a long-term non-GAAP tax rate. The reconciliations included in these filings help readers understand the relationship between GAAP and non-GAAP results.
Through this SEC filings page, users can review annual reports (Form 10-K) for comprehensive discussions of Silicon Labs’ business, markets, and risks, and quarterly reports (Form 10-Q) for interim financial updates. Current reports (Form 8-K) provide timely information on earnings releases and other material developments. Where applicable, insider transaction reports (Form 4) can be used to track equity transactions by directors and officers.
Stock Titan enhances access to these documents with AI-powered summaries that highlight key sections, explain complex accounting or tax adjustments, and surface important changes across reporting periods. Real-time updates from EDGAR ensure that new Silicon Labs filings appear promptly, helping users quickly locate the information most relevant to their analysis of SLAB stock and the company’s financial reporting practices.
Silicon Laboratories Inc. is asking stockholders to approve a merger with Texas Instruments. If approved, Merger Sub will merge into Silicon Labs and Silicon Labs will become a wholly owned subsidiary of Texas Instruments.
Each outstanding share of Silicon Labs common stock will convert into the right to receive $231.00 in cash, less applicable withholding. The Board unanimously recommends that stockholders vote FOR the Merger Proposal, the Compensation Proposal and the Adjournment Proposal. The Special Meeting is scheduled for April 30, 2026 and the Record Date was March 23, 2026 (32,968,416 shares outstanding as of that date).
Silicon Laboratories Inc Schedule 13G/A: The Vanguard Group filed an amendment reporting zero shares beneficially owned and 0% of Silicon Laboratories Inc common stock. The filing explains an internal realignment effective January 12, 2026 under SEC Release No. 34-39538 that caused certain Vanguard subsidiaries and business divisions to report holdings separately.
The form states Vanguard's subsidiaries continue the same investment strategies previously pursued and that The Vanguard Group, Inc. no longer is deemed to have beneficial ownership of securities held by those entities.
Silicon Laboratories Inc. is asking stockholders to approve a merger under which Texas Instruments will acquire Silicon Labs for $231.00 in cash per share. The Board unanimously approved and recommended the Merger Proposal and Silicon Labs’ financial advisor, Qatalyst Partners, rendered a written fairness opinion dated February 3, 2026.
The transaction requires stockholder approval and regulatory clearances, including filings under the HSR Act and certain foreign antitrust and foreign direct investment reviews. The proxy discloses termination fee mechanics ($259 million payable by Silicon Labs; $499 million payable by Texas Instruments) and states the companies expect to close, subject to approvals and conditions, in the first half of 2027.
Silicon Laboratories Inc. is asking shareholders to vote at a virtual annual meeting on April 23, 2026. Investors will elect two Class I directors, ratify Deloitte & Touche as auditor, cast an advisory vote on 2025 executive pay, and approve amendments to the 2009 Stock Incentive Plan.
The company reports 2025 revenue growth of 34%, describing it as a strong recovery after a 2024 inventory-driven correction. It seeks authorization for an additional 1,400,000 shares under the stock plan, which management estimates would bring total potential equity overhang to about 10.01%. The proxy also explains the 2025 switch from Ernst & Young to Deloitte following a 2023 material weakness in inventory accounting controls, and outlines detailed board independence, committee structure, director compensation and sustainability governance.
FMR LLC filed an amendment to a Schedule 13G reporting beneficial ownership of 697,454.83 shares, representing 2.1% of Silicon Laboratories Inc. common stock. The filing lists sole dispositive power of 697,454.83 shares and indicates ownership of 5% or less of the class. Signatures show authorization by Stephanie J. Brown on behalf of FMR LLC and Abigail P. Johnson, dated 03/05/2026.
Silicon Laboratories’ Chief Accounting Officer Mark D. Mauldin reported routine equity compensation changes. On February 15, 2026, he acquired 3,153 restricted stock units (RSUs) at $0 per share, which will vest in three equal annual installments under the company’s 2009 Stock Incentive Plan.
On February 13, 2026, 356 shares of common stock at $207.27 per share were disposed of to cover taxes upon vesting of a prior award. Following these transactions, he directly beneficially owned 21,930 shares of Silicon Laboratories common stock.
Silicon Laboratories Inc. executive Brandon Tolany reported an equity award of 8,669 shares of common stock. The Form 4 shows a grant coded as an acquisition at a price of $0 per share, increasing his directly held stake to 71,050 common shares.
The award is in the form of restricted stock units (RSUs), with each RSU convertible into one share of common stock. One-third of the RSUs will vest on each of the first three anniversaries of the February 15, 2026 grant date under the company’s 2009 Stock Incentive Plan.
Silicon Laboratories senior vice president and general manager Robert J. Conrad received an equity grant in the form of 8,669 shares of common stock on February 15, 2026. These were awarded at a price of $0 per share as part of his compensation.
The award consists of restricted stock units that each convert into one share of common stock. One-third of the RSUs will vest on each of the first three anniversaries of the grant date under Silicon Laboratories’ 2009 Stock Incentive Plan. Following this grant, Conrad directly holds 34,049 shares of Silicon Laboratories common stock.
Johnson Robert Matthew reported acquisition or exercise transactions in a Form 4 filing for SLAB. The filing lists transactions totaling 25,218 shares. Following the reported transactions, holdings were 98,906 shares.